Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function

European Journal of Immunology

Volumn 41, Issue 11, 2011, Pages 3281-3290

  Abdelrazik, Heba ^a,b,c   Spaggiari, Grazia M ^b   Chiossone, Laura ^b   Moretta, Lorenzo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Human platelet lysate; Mesenchymal stromal cells; NK cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALLOANTIGEN; ALPHA4 INTEGRIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; NATURAL KILLER CELL RECEPTOR NKG2D; NECTIN 1; NECTIN 2; RANTES; THY 1 ANTIGEN;

ARTICLE; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN PLATELET LYSATE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE; UPREGULATION;

BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MESENCHYMAL STEM CELLS; T-LYMPHOCYTES;

EID: 80054892015     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141542     Document Type: Article

References (48)

1. von Bonin, M., Stolzel, F., Goedecke, A., Richter, K., Wuschek, N., Holig, K., Platzbecker, U. et al., Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009. 43: 245-251.
2. Sensebe, L. and Bourin, P., Mesenchymal stem cells for therapeutic purposes. Transplantation 2009. 87: S49-S53.
3. Perez-Ilzarbe, M., Diez-Campelo, M., Aranda, P., Tabera, S., Lopez, T., del Canizo, C., Merino, J. et al., Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 2009. 49: 1901-1910.
4. Bieback, K., Hecker, A., Kocaomer, A., Lannert, H., Schallmoser, K., Strunk, D. and Kluter, H., Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009. 27: 2331-2341.
5. English, K., French, A. and Wood, K. J., Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 2010. 7: 431-442.
6. Doucet, C., Ernou, I., Zhang, Y., Llense, J. R., Begot, L., Holy, X. and Lataillade, J. J., Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 2005. 205: 228-236.
7. Bernardo, M. E., Avanzini, M. A., Perotti, C., Cometa, A. M., Moretta, A., Lenta, E., Del Fante, C. et al., Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J. Cell. Physiol. 2007. 211: 121-130.
8. Harrison, P. and Cramer, E. M., Platelet alpha-granules. Blood Rev. 1993. 7: 52-62.
9. Schallmoser, K., Rohde, E., Bartmann, C., Obenauf, A. C., Reinisch, A. and Strunk, D., Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Biomed. Mater. Eng. 2009. 19: 271-276.
10. Schallmoser, K. and Strunk, D., Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J. Vis. Exp. 2010. DOI: 10.3791/1523.
11. Capelli, C., Domenghini, M., Borleri, G., Bellavita, P., Poma, R., Carobbio, A., Mico, C. et al., Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007. 40: 785-791.
12. Schallmoser, K., Rohde, E., Reinisch, A., Bartmann, C., Thaler, D., Drexler, C., Obenauf, A. C. et al., Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng. Part C Methods 2008. 14: 185-196.
13. Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Stadelmeyer, E., Drexler, C. et al., Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007. 47: 1436-1446.
14. Blande, I. S., Bassaneze, V., Lavini-Ramos, C., Fae, K. C., Kalil, J., Miyakawa, A. A., Schettert, I. T. and Krieger, J. E., Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 2009. 49: 2680-2685.
15. Schallmoser, K., Bartmann, C., Rohde, E., Bork, S., Guelly, C., Obenauf, A. C., Reinisch, A. et al., Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica 2010. 95: 867-874.
16. Tarte, K., Gaillard, J., Lataillade, J. J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A. et al., Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010. 115: 1549-1553.
17. Sensebe, L., Krampera, M., Schrezenmeier, H., Bourin, P. and Giordano, R., Mesenchymal stem cells for clinical application. Vox Sang 2010. 98: 93-107.
18. Reinisch, A. and Strunk, D., Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J. Vis. Exp. 2010. DOI 10.3791/1525.
19. Castegnaro, S., Chieregato, K., Maddalena, M., Albiero, E., Visco, C., Madeo, D., Pegoraro, M. and Rodeghiero, F., Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue. Curr. Stem Cell Res. Ther. 2011. 6: 105-114.
20. Carrancio, S., Lopez-Holgado, N., Sanchez-Guijo, F. M., Villaron, E., Barbado, V., Tabera, S., Diez-Campelo, M. et al., Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp. Hematol. 2008. 36: 1014-1021.
21. Reinisch, A., Bartmann, C., Rohde, E., Schallmoser, K., Bjelic-Radisic, V., Lanzer, G., Linkesch, W. and Strunk, D., Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen. Med. 2007. 2: 371-382.
22. Avanzini, M. A., Bernardo, M. E., Cometa, A. M., Perotti, C., Zaffaroni, N., Novara, F., Visai, L. et al., Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 2009. 94: 1649-1660.
23. Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C. and Moretta, L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006. 107: 1484-1490.
24. Rasmusson, I., Ringden, O., Sundberg, B. and Le Blanc, K., Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 2005. 305: 33-41.
25. Centeno, C. J., Schultz, J. R., Cheever, M., Robinson, B., Freeman, M. and Marasco, W., Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr. Stem Cell Res. Ther. 2010. 5: 81-93.
26. Bocelli-Tyndall, C., Zajac, P., Di Maggio, N., Trella, E., Benvenuto, F., Iezzi, G., Scherberich, A. et al., FGF-2 and PDGF, but not Platelet Lysate (PL), induce proliferation dependent, functional MHC-classII antigen in human mesenchymal stem cells (hMSC). Arthritis Rheum. 2010. 62: 3815-3825.
27. Lange, C., Cakiroglu, F., Spiess, A. N., Cappallo-Obermann, H., Dierlamm, J. and Zander, A. R., Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J. Cell. Physiol. 2007. 213: 18-26.
28. Muller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S. et al., Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006. 8: 437-444.
29. Centeno, C. J., Busse, D., Kisiday, J., Keohan, C., Freeman, M. and Karli, D., Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med. Hypotheses 2008. 71: 900-908.
30. Lataillade, J. J., Doucet, C., Bey, E., Carsin, H., Huet, C., Clairand, I., Bottollier-Depois, J. F. et al., New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen. Med. 2007. 2: 785-794.
31. Bernardo, M. E., Avanzini, M. A., Ciccocioppo, R., Perotti, C., Cometa, A. M., Moretta, A., Marconi, M. et al., Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy 2009: 1-12.
32. Chevallier, N., Anagnostou, F., Zilber, S., Bodivit, G., Maurin, S., Barrault, A., Bierling, P. et al., Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010. 31: 270-278.
33. Salvade, A., Della Mina, P., Gaddi, D., Gatto, F., Villa, A., Bigoni, M., Perseghin, P. et al., Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng. Part C Methods 2010. 16: 201-214.
34. Lucchini, G., Introna, M., Dander, E., Rovelli, A., Balduzzi, A., Bonanomi, S., Salvade, A. et al., Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol. Blood Marrow Transplant. 2010. 16: 1293-1301.
35. Weng, J. Y., Du, X., Geng, S. X., Peng, Y. W., Wang, Z., Lu, Z. S., Wu, S. J. et al., Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010. 45: 1732-1740.
36. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E. et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008. 371: 1579-1586.
37. Uccelli, A., Moretta, L. and Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008. 8: 726-736.
38. Joo, S. Y., Cho, K. A., Jung, Y. J., Kim, H. S., Park, S. Y., Choi, Y. B., Hong, K. M. et al., Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. Cytotherapy 2010. 12: 361-370.
39. Perez-Simon, J. A., Sanchez-Abarca, I., Diez-Campelo, M., Caballero, D. and San Miguel, J., Chronic graft-versus-host disease: pathogenesis and clinical management. Drugs 2006. 66: 1041-1057.
40. Nachbaur, D. and Kircher, B., Dendritic cells in allogeneic hematopoietic stem cell transplantation. Leuk. Lymphoma 2005. 46: 1387-1396.
41. Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C. and Moretta, L., Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2, 3-dioxygenase and prostaglandin E2. Blood 2008. 111: 1327-1333.
42. Moretta, L., Locatelli, F., Pende, D., Mingari, M. C. and Moretta, A., Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. Tissue Antigens 2010. 75: 103-109.
43. Moretta, L., Locatelli, F., Pende, D., Marcenaro, E., Mingari, M. C. and Moretta, A., Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 2010. 117: 764-771.
44. Locatelli, F., Pende, D., Maccario, R., Mingari, M. C., Moretta, A. and Moretta, L., Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. Clin. Immunol. 2009. 133: 171-178.
45. Spaggiari, G. M., Abdelrazik, H., Becchetti, F. and Moretta, L., MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009. 113: 6576-6583.
46. Moretta, A., Locatelli, F., Mingrat, G., Rondini, G., Montagna, D., Comoli, P., Gandossini, S. et al., Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood. Bone Marrow Transplant. 1999. 24: 1161-1166.
47. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E. et al., Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 1999. 190: 1505-1516.
48. Alter, G., Malenfant, J. M. and Altfeld, M., CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol Methods 2004. 294: 15-22.